3,000 Daily Steps Linked to Slower Alzheimer's Decline — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Researchers tracked almost 300 older adults with early Alzheimer's brain signs for 9 to 11 years using pedometers and found physical activity reduced accumulation of misfolded tau proteins in specific brain areas — but did not reduce the toxic amyloid plaques most current Alzheimer's treatments focus on.
- More active participants showed nearly half the cognitive and functional decline, with measurable benefits appearing at just 3,000 daily steps (about 30 minutes of walking) and peaking in the 5,000-7,500 range before plateauing — undercutting the popular 10,000-step target.
- A 2022 UK study of 78,430 adults followed for seven years found a 25% reduction in dementia risk at 3,800 daily steps, rising to 50% at 9,800 steps.
- A separate UK study of 1,139 people over 50 tracked for 8 to 10 years found moderately to vigorously active individuals had a 34-50% lower dementia risk.
- A small Nordic walking trial of 15 people with mild-to-moderate Alzheimer's found participants maintained brain function over 24 weeks, with some functions improving — while 15 controls on standard care showed decline or no improvement.
- The study's authors flagged limitations: a small, mostly white, well-educated US sample, no adjustment for correlated healthy habits (cardiovascular health, sleep, diet), and a possible reverse-causation problem in which early Alzheimer's symptoms — including hearing loss — may be reducing activity rather than the other way around.
Why it matters: For older adults seeking a realistic exercise target, the study links a 30-minute daily walk — not the 10,000-step goal — to measurably slower cognitive decline, though the small US sample and uncounted lifestyle confounds keep this short of a clinical prescription.
Ask SkimNews
